BioNeutra Global Corporation
BGACF
Get informed when a big investor buys or sells
+ FollowMarket Cap$260.11K
Close$
Share Statistics
| Market cap | $260,113.00 |
|---|---|
| Enterprise Value | $6.64 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.05 |
| Beta | 1.01 |
| Outstanding Shares | 41,224,000 |
Return
| Return on Equity | 7.41% |
|---|---|
| Return on Assets | -4.49% |
| Return on Invested Capital | -10.83% |
Valuation & Multiples
| P/E Ratio | -0.16 |
|---|---|
| PEG | 0.23 |
| Price to Sales | - |
| Price to Book Ratio | -0.01 |
| Enterprise Value to Revenue | 0.61 |
| Enterprise Value to EBIT | 37.8 |
| Enterprise Value to Net Income | -11 |
| Total Debt to Enterprise | 1.08 |
| Debt to Equity | -0.87 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
October 5, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About BioNeutra Global Corporation
51 employees
CEO: Jianhua Zhu BioNeutra Global Corporation, along with its associated companies, specializes in the development, manufacturing, and marketing of food ingredients. These ingredients are designed for use in nutraceuticals, functional foods, and conventi...